Johan, Associate Professor at the University of Lund, Sweden, obtained his PhD in a collaboration between Lund University and AstraZeneca R&D Lund. In 2001 he co-founded Ludesi AB. In 2003, Johan joined the Institute for Systems Biology in Seattle, and in 2004, he transferred to the Aebersold lab at the ETH Zurich, where he was involved in the development and application of targeted proteomics technologies and co-founded Biognosys.